FibroGen
Why Robinhood?
You can watch FibroGen and buy or sell other stocks, ETFs, and their options commission-free!About FGEN
Kyntra Bio, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer.
FGEN Key Statistics
Stock Snapshot
With a market cap of 30.44M, FibroGen(FGEN) trades at $7.52. The stock has a price-to-earnings ratio of 0.27.
FibroGen(FGEN) stock opened on 2026-07-13 at —. The price climbed to — and dipped to —.
The FibroGen(FGEN)'s current trading volume is 0, compared to an average daily volume of 17.49K.
In the last year, FibroGen(FGEN) shares hit a 52-week high of $12.60 and a 52-week low of $6.32.
In the last year, FibroGen(FGEN) shares hit a 52-week high of $12.60 and a 52-week low of $6.32.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.